Scientists have discovered how the highly infectious and sometimes deadly hepatitis C virus (HCV) 'ghosts' our immune system and remains undiagnosed in many people. By targeting a specific protein, scientists hope to restore effective immune responses against HCV, particularly in patients who do not respond to existing therapy.